Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J cuts jobs, invests in core brands

This article was originally published in The Tan Sheet

Executive Summary

Johnson & Johnson will cut 6 percent to 7 percent of its global workforce in response to external pressures on the health care industry, the firm said Nov. 3. Cuts will come from all the core businesses: pharmaceuticals, medical devices and consumer products. Job eliminations will take place globally, but mostly outside the U.S., and will reduce "layers of management," CEO William Weldon said during a same-day conference call. The plan will yield pre-tax cost savings of $1.4 billion to $1.7 billion in 2011, with $800 million to $900 million expected to be achieved in 2010. J&J plans to invest the savings in key innovation opportunities and core businesses, including the mouthwash Listerine, allergy-relief medication Zyrtec and skin care lines Aveeno and Neutrogena, Weldon said
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS103505

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel